Published: 5 October 2026
Author(s): Paola Gargiulo, Federica Marzano, Laura Liccardi, Savina Nodari, Matteo Cameli, Francesco Giallauria, Federico Guerra, Egidio Imbalzano, Gianfranco Sinagra, Stefano Carugo, Carmine Pizzi, Francesco Cipollone, Francesco Grigioni, Saverio Muscoli, Alberto Polimeni, Pasquale Perrone Filardi, on behalf of the CardioMET investigators
Section: Original Article
To assess the implementation of guideline-directed glucose-lowering therapies with proven cardiovascular (CV) benefit in individuals with type 2 diabetes mellitus (T2DM) attending Italian outpatient cardiology clinics.
